Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 37 |
| List of Tables | 33 | 5 |
| List of Figures | 38 | 1 |
| Introduction | 39 | 1 |
| Global Markets Direct Report Coverage | 39 | 1 |
| Asthma Overview | 40 | 1 |
| Therapeutics Development | 41 | 2 |
| Pipeline Products for Asthma Overview | 41 | 1 |
| Pipeline Products for Asthma Comparative Analysis | 42 | 1 |
| Asthma Therapeutics under Development by Companies | 43 | 12 |
| Asthma Therapeutics under Investigation by Universities/Institutes | 55 | 2 |
| Asthma Pipeline Products Glance | 57 | 4 |
| Late Stage Products | 57 | 1 |
| Clinical Stage Products | 58 | 1 |
| Early Stage Products | 59 | 1 |
| Unknown Stage Products | 60 | 1 |
| Asthma Products under Development by Companies | 61 | 17 |
| Asthma Products under Investigation by Universities/Institutes | 78 | 2 |
| Asthma Companies Involved in Therapeutics Development | 80 | 128 |
| 4D Pharma Plc | 80 | 1 |
| AB Science SA | 81 | 1 |
| AbbVie Inc | 82 | 1 |
| Abeome Corporation | 83 | 1 |
| Accolade Pharmaceuticals, LLC | 84 | 1 |
| Acorda Therapeutics, Inc. | 85 | 1 |
| Adamis Pharmaceuticals Corporation | 86 | 1 |
| Advinus Therapeutics Ltd | 87 | 1 |
| Afferent Pharmaceuticals, Inc. | 88 | 1 |
| ALK-Abello A/S | 89 | 1 |
| Allergopharma GmbH &Co. KG | 90 | 1 |
| Almirall, S.A. | 91 | 1 |
| Amakem NV | 92 | 1 |
| Amgen Inc. | 93 | 1 |
| AnaptysBio, Inc. | 94 | 1 |
| AnGes MG, Inc. | 95 | 1 |
| Antisense Therapeutics Limited | 96 | 1 |
| ARA Healthcare Pvt. Ltd. | 97 | 1 |
| Array BioPharma Inc. | 98 | 1 |
| ASIT biotech s.a. | 99 | 1 |
| Astellas Pharma Inc. | 100 | 1 |
| AstraZeneca Plc | 101 | 1 |
| Asubio Pharma Co., Ltd. | 102 | 1 |
| Aurigene Discovery Technologies Limited | 103 | 1 |
| Axikin Pharmaceuticals, Inc. | 104 | 1 |
| Bioncotech Therapeutics SL | 105 | 1 |
| Biotec Pharmacon ASA | 106 | 1 |
| Boehringer Ingelheim GmbH | 107 | 1 |
| CalciMedica, Inc. | 108 | 1 |
| Cellceutix Corporation | 109 | 1 |
| Cellular Biomedicine Group, Inc. | 110 | 1 |
| Celon Pharma Sp. z o.o. | 111 | 1 |
| Chiesi Farmaceutici SpA | 112 | 1 |
| Circassia Pharmaceuticals Plc | 113 | 1 |
| Cognosci, Inc. | 114 | 1 |
| CSL Limited | 115 | 1 |
| Cumberland Pharmaceuticals, Inc. | 116 | 1 |
| Cynata Therapeutics Limited | 117 | 1 |
| Daiichi Sankyo Company, Limited | 118 | 1 |
| F. Hoffmann-La Roche Ltd. | 119 | 1 |
| Foresee Pharmaceuticals, LLC | 120 | 1 |
| Fountain Biopharma Inc. | 121 | 1 |
| Genentech, Inc. | 122 | 1 |
| GlaxoSmithKline Plc | 123 | 1 |
| Griffin Discoveries BV | 124 | 1 |
| Han Wha Pharma Co., Ltd. | 125 | 1 |
| HitGen LTD | 126 | 1 |
| Hydra Biosciences, Inc. | 127 | 1 |
| iCeutica, Inc. | 128 | 1 |
| iCo Therapeutics Inc. | 129 | 1 |
| Immupharma Plc | 130 | 1 |
| Infinity Pharmaceuticals, Inc. | 131 | 1 |
| INOXIA Lifesciences GmbH | 132 | 1 |
| Intech Biopharm Ltd | 133 | 1 |
| Invion Limited | 134 | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 135 | 1 |
| Johnson &Johnson | 136 | 1 |
| Kissei Pharmaceutical Co., Ltd. | 137 | 1 |
| Kolltan Pharmaceuticals, Inc. | 138 | 1 |
| KPI Therapeutics, Inc. | 139 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 140 | 1 |
| Lead Discovery Center GmbH | 141 | 1 |
| LegoChem Biosciences, Inc | 142 | 1 |
| Ligand Pharmaceuticals, Inc. | 143 | 1 |
| Lpath, Inc. | 144 | 1 |
| Mabtech Limited | 145 | 1 |
| Marinomed Biotechnologie GmbH | 146 | 1 |
| MedImmune, LLC | 147 | 1 |
| Merck &Co., Inc. | 148 | 1 |
| Mitsubishi Tanabe Pharma Corporation | 149 | 1 |
| Mycenax Biotech Inc. | 150 | 1 |
| NAL Pharmaceuticals Ltd. | 151 | 1 |
| NeoPharm Co., Ltd. | 152 | 1 |
| Novartis AG | 153 | 1 |
| Omeros Corporation | 154 | 1 |
| Ono Pharmaceutical Co., Ltd. | 155 | 1 |
| OPKO Health, Inc. | 156 | 1 |
| Orbis Biosciences Inc | 157 | 1 |
| Orion Oyj | 158 | 1 |
| Oxagen Limited | 159 | 1 |
| Palatin Technologies, Inc. | 160 | 1 |
| Panacea Biotec Limited | 161 | 1 |
| Panmira Pharmaceuticals, LLC. | 162 | 1 |
| Paradigm Biopharmaceuticals Limited | 163 | 1 |
| Peptinnovate Ltd | 164 | 1 |
| Pfizer Inc. | 165 | 1 |
| PharmaLundensis AB | 166 | 1 |
| Pharmaxis Limited | 167 | 1 |
| Pieris Pharmaceuticals Inc | 168 | 1 |
| Pila Pharma AB | 169 | 1 |
| Polyphor Ltd. | 170 | 1 |
| Promedior, Inc. | 171 | 1 |
| Prommune, Inc. | 172 | 1 |
| Protectimmun GmbH | 173 | 1 |
| Prous Institute for Biomedical Research S.A. | 174 | 1 |
| Pulmagen Therapeutics LLP | 175 | 1 |
| Pulmokine, Inc. | 176 | 1 |
| Re-Pharm Limited | 177 | 1 |
| Regeneron Pharmaceuticals Inc | 178 | 1 |
| Respiratorius AB | 179 | 1 |
| ReveraGen BioPharma, Inc. | 180 | 1 |
| Rhizen Pharmaceuticals S.A. | 181 | 1 |
| Saje Pharma, LLC | 182 | 1 |
| Shire Plc | 183 | 1 |
| Spring Bank Pharmaceuticals, Inc. | 184 | 1 |
| Stallergenes Greer plc | 185 | 1 |
| Sterna biologicals Gmbh &Co KG | 186 | 1 |
| Sumitomo Dainippon Pharma Co., Ltd. | 187 | 1 |
| Sun Pharma Advanced Research Company Ltd. | 188 | 1 |
| Sunovion Pharmaceuticals Inc. | 189 | 1 |
| Swecure AB | 190 | 1 |
| Synermore Biologics Co Ltd | 191 | 1 |
| Synovo GmbH | 192 | 1 |
| Syntrix Biosystems, Inc. | 193 | 1 |
| TaiwanJ Pharmaceuticals Co., Ltd. | 194 | 1 |
| Takeda Pharmaceutical Company Limited | 195 | 1 |
| Teva Pharmaceutical Industries Ltd. | 196 | 1 |
| The International Biotechnology Center (IBC) Generium | 197 | 1 |
| Therabron Therapeutics, Inc. | 198 | 1 |
| Theravance Biopharma, Inc. | 199 | 1 |
| Tolerys SA | 200 | 1 |
| United BioPharma, Inc. | 201 | 1 |
| Vectura Group Plc | 202 | 1 |
| Verona Pharma Plc | 203 | 1 |
| WhanIn Pharmaceutical Co., Ltd. | 204 | 1 |
| Xencor, Inc. | 205 | 1 |
| Yungjin Pharm. Co., Ltd. | 206 | 1 |
| Zambon Company S.p.A. | 207 | 1 |
| Asthma Therapeutics Assessment | 208 | 37 |
| Assessment by Monotherapy Products | 208 | 1 |
| Assessment by Combination Products | 209 | 1 |
| Assessment by Target | 210 | 12 |
| Assessment by Mechanism of Action | 222 | 19 |
| Assessment by Route of Administration | 241 | 2 |
| Assessment by Molecule Type | 243 | 2 |
| Drug Profiles | 245 | 430 |
| (beclomethasone dipropionate + formoterol fumarate + glycopyrrolate) Drug Profile | 245 | 3 |
| (budesonide + procaterol hydrochloride) Drug Profile | 248 | 1 |
| (budesonide + formoterol fumarate + glycopyrrolate) Drug Profile | 249 | 2 |
| (budesonide + formoterol fumarate) Drug Profile | 251 | 1 |
| (dectrekumab + VAK-694) Drug Profile | 252 | 1 |
| (fluticasone furoate + umeclidinium bromide + vilanterol trifenatate) Drug Profile | 253 | 3 |
| (fluticasone propionate + formoterol fumarate) Drug Profile | 256 | 5 |
| (fluticasone propionate + glycopyrronium bromide + salmeterol xinafoate) Drug Profile | 261 | 1 |
| (fluticasone propionate + salmeterol xinafoate) Drug Profile | 262 | 1 |
| (fluticasone propionate + salmeterol xinafoate) Drug Profile | 263 | 1 |
| (fluticasone propionate + salmeterol xinafoate) Drug Profile | 264 | 2 |
| (fluticasone propionate + salmeterol xinafoate) Drug Profile | 266 | 1 |
| (fluticasone propionate + salmeterol xinafoate) MDI Drug Profile | 267 | 1 |
| (fluticasone propionate + theophylline) Drug Profile | 268 | 1 |
| (glycopyrrolate + indacaterol maleate + mometasone fuorate) Drug Profile | 269 | 1 |
| (indacaterol maleate + mometasone furoate) Drug Profile | 270 | 2 |
| (Inhaled Corticosteroid + Long-acting Muscarinic Antagonist) Drug Profile | 272 | 1 |
| (Long Acting Beta-2 Agonist + Long Acting Muscarinic Receptor Antagonist) Drug Profile | 273 | 1 |
| AB-8779 Drug Profile | 274 | 1 |
| abediterol napadisylate Drug Profile | 275 | 2 |
| AcTMP-1 Drug Profile | 277 | 1 |
| ADC-3277 Drug Profile | 278 | 1 |
| ADC-3680 Drug Profile | 279 | 2 |
| ADC-7405 Drug Profile | 281 | 1 |
| ADC-8316 Drug Profile | 282 | 1 |
| ADC-9971 Drug Profile | 283 | 1 |
| ADP-31417 Drug Profile | 284 | 1 |
| AF-219 Drug Profile | 285 | 4 |
| Allergen for Asthma and Perennial Allergic Rhinitis Drug Profile | 289 | 1 |
| Altepan Drug Profile | 290 | 1 |
| AM-211 Drug Profile | 291 | 1 |
| AM-461 Drug Profile | 292 | 1 |
| AMA-0247 Drug Profile | 293 | 1 |
| ANB-020 Drug Profile | 294 | 2 |
| AR-460770 Drug Profile | 296 | 1 |
| ARA-6 Drug Profile | 297 | 1 |
| arabinogalactan Drug Profile | 298 | 1 |
| ASB-14780 Drug Profile | 299 | 1 |
| ASLAN-004 Drug Profile | 300 | 1 |
| ASM-8 Drug Profile | 301 | 2 |
| ASP-3258 Drug Profile | 303 | 1 |
| ASP-7266 Drug Profile | 304 | 1 |
| ATL-1102 Drug Profile | 305 | 5 |
| AW/EPO-002 Drug Profile | 310 | 1 |
| AW/EPO-003 Drug Profile | 311 | 1 |
| AW/EPOPD-01 Drug Profile | 312 | 1 |
| AW/EPOPD-02 Drug Profile | 313 | 1 |
| AW/EPOPD-06 Drug Profile | 314 | 1 |
| AX-024 Drug Profile | 315 | 1 |
| AZD-0449 Drug Profile | 316 | 1 |
| AZD-1419 Drug Profile | 317 | 2 |
| AZD-7594 Drug Profile | 319 | 1 |
| AZD-8871 Drug Profile | 320 | 1 |
| BA-024 Drug Profile | 321 | 1 |
| beclomethasone dipropionate Drug Profile | 322 | 1 |
| bedoradrine sulfate Drug Profile | 323 | 3 |
| benralizumab Drug Profile | 326 | 4 |
| bertilimumab Drug Profile | 330 | 4 |
| beta-escin Drug Profile | 334 | 1 |
| BI-1060469 Drug Profile | 335 | 1 |
| Biologic for Allergic Asthma and Allergies Drug Profile | 336 | 1 |
| CBP-201 Drug Profile | 337 | 1 |
| CG-459 Drug Profile | 338 | 1 |
| CHF-6001 Drug Profile | 339 | 2 |
| CM-3457 Drug Profile | 341 | 1 |
| CNB-001 Drug Profile | 342 | 2 |
| CNTO-3157 Drug Profile | 344 | 1 |
| COG-130 Drug Profile | 345 | 1 |
| CPL-407105 Drug Profile | 346 | 1 |
| CSL-311 Drug Profile | 347 | 1 |
| CSY-0073 Drug Profile | 348 | 1 |
| D-9030 Drug Profile | 349 | 1 |
| dalazatide Drug Profile | 350 | 5 |
| DIS-COM-BRA Drug Profile | 355 | 1 |
| Drug to Inhibit IL-33 for Asthma Drug Profile | 356 | 1 |
| Drug to Inhibit PI3 Kinase Delta for Asthma Drug Profile | 357 | 1 |
| Drugs to Inhibit Aldose Reductase for Immunology, Ophthalmology, Infectious Disease, Metabolic and Respiratory Disorders Drug Profile | 358 | 1 |
| Drugs to Inhibit c-Kit/PDGFR for Asthma Drug Profile | 359 | 1 |
| Drugs to Inhibit CYP11A1 for Peanut Allergy and Asthma Drug Profile | 360 | 1 |
| dupilumab Drug Profile | 361 | 7 |
| duvelisib Drug Profile | 368 | 11 |
| EP-67 Drug Profile | 379 | 1 |
| Epsi-Gam Drug Profile | 380 | 2 |
| ET-523 Drug Profile | 382 | 1 |
| FB-825 Drug Profile | 383 | 1 |
| fevipiprant Drug Profile | 384 | 2 |
| fluticasone furoate Drug Profile | 386 | 3 |
| fluticasone propionate Drug Profile | 389 | 1 |
| FP-025 Drug Profile | 390 | 1 |
| FX-125L Drug Profile | 391 | 2 |
| glycopyrrolate Drug Profile | 393 | 2 |
| glycopyrrolate Drug Profile | 395 | 2 |
| glycopyrrolate Drug Profile | 397 | 4 |
| GNE-293 Drug Profile | 401 | 1 |
| GNR-044 Drug Profile | 402 | 1 |